Showing results (11-20 of 151) with videos related to
Sort By:
Pageof 16
Journal of Pain Research|December 18, 2015
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic painIsh K Khanna, Sivaram PillarisettiClinica Chimica Acta; International Journal of Clinical Chemistry|June 13, 2006
Vascular lipases, inflammation and atherosclerosisSumera N Hasham, Sivaram PillarisettiCardiovascular Diabetology|October 7, 2005
Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosisWenlan Duan, Latha Paka, Sivaram PillarisettiCurrent Pharmaceutical Biotechnology|August 22, 2006
Emerging peptide therapeutics for inflammatory diseasesMaya Vally, Sujatha Seenu, Sivaram PillarisettiDrug Discovery Today|June 13, 2009
Recent advances in glucokinase activators for the treatment of type 2 diabetesManojit PalCurrent Medicinal Chemistry|September 15, 2009
Medicinal chemistry approaches for glucokinase activation to treat type 2 diabetesManojit PalCurrent Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
Atherosclerosis -- new targets and therapeuticsSivaram Pillarisetti, Christopher W Alexander, Uday SaxenaExpert Opinion on Therapeutic Targets|January 24, 2003
New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discoveryUday Saxena, Richard T Timmer, Sivaram PillarisettiDrug Discovery Today|September 1, 2009
Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseasesSivaram Pillarisetti, Christopher W Alexander, Ish KhannaDiabetes|December 17, 2008
Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistanceIndira Padmalayam, Sumera Hasham, Uday Saxena, et al.Pageof 16